Isabelle Riviere

Title: The Innovative Contributions of Isabelle Riviere

Introduction

Isabelle Riviere is a prominent inventor based in New York, NY, known for her significant contributions to the field of gene therapy and antibody development. With a total of two patents to her name, she has made remarkable strides in addressing critical health issues.

Latest Patents

Her latest patents include groundbreaking work on globin gene therapy for treating hemoglobinopathies. This patent provides expression cassettes that facilitate the expression of a globin gene or its functional portions, along with vectors and cells transduced with these cassettes. Additionally, she has developed methods for treating hemoglobinopathies by administering an effective amount of transduced cells to patients. Another notable patent involves anti-CD20 antibodies, which are crucial for treatment and diagnosis. This patent outlines the production of anti-CD20 antibodies using CD20 antigens and methods for generating these antibodies.

Career Highlights

Isabelle has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and the University of Washington. Her work in these organizations has allowed her to contribute to significant advancements in medical research and treatment methodologies.

Collaborations

Isabelle has collaborated with notable colleagues, including Xiuyan Wang and Ouathek Ouerfelli, enhancing her research and innovation efforts.

Conclusion

Isabelle Riviere's innovative work in gene therapy and antibody development showcases her dedication to improving healthcare solutions. Her patents reflect her commitment to advancing medical science and addressing critical health challenges.